SCHEMBL6220362

SCHEMBL6220362

[C-]#[N+]C(CCCOCc1ccccc1)S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.42
▸ GAA P10253 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ LMNA P02545 3/20 0.40
▸ AR P10275 1/20 0.39
▸ ATM Q13315 2/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ BCHE P06276 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ MAPT P10636 3/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ PIR O00625 1/20 0.37
▸ MMP3 P08254 2/20 0.36
▸ MCHR1 Q99705 1/20 0.36
▸ MMP2 P08253 1/20 0.36
▸ CNR2 P34972 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6966789 0.83 ALDH1A1 (0.49) ALDH1A1ATMCYP1A2CYP3A4BCHE
SCHEMBL9614028 0.81 MMP2 (0.51) ALDH1A1GAAPKMLMNAAR
SCHEMBL1307134 0.77 CA2 (0.48) ALDH1A1GAAATMCYP1A2CYP3A4
SCHEMBL29956354 0.76 MCHR1 (0.44) ALDH1A1GAALMNACYP3A4CA12
SCHEMBL186606 0.76 CA12 (0.43) ALDH1A1GAALMNACYP3A4CA12
SCHEMBL8607431 0.76 ALDH1A1 (0.42) ALDH1A1GAAPKMLMNAAR
SCHEMBL31106589 0.74 MCHR1 (0.47) ALDH1A1GAALMNAATMCYP3A4
SCHEMBL30828010 0.74 ALDH1A1 (0.43) ALDH1A1GAALMNACYP3A4CA12
SCHEMBL31106597 0.74 MCHR1 (0.47) ALDH1A1GAALMNAATMCYP3A4
SCHEMBL2246161 0.74 ALDH1A1 (0.49) ALDH1A1GAAPKMLMNAAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1549635-A1 3,4-DISUBSTITUTED PYRROLES AND THEIR FOR USE IN TREATING INFLAMMATORY DISEASES JANSSEN PHARMACEUTICA N.V. (BE) 2005-07-06 — — EP disclosed
US-20050043331-A1 Substituted 3-(2,5-disubstituted)pyridyl-4-aryl pyrroles for treating inflammatory diseases JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-24 — — US disclosed
WO-2004029040-A1 3,4-DISUBSTITUTED PYRROLES AND THEIR FOR USE IN TREATING INFLAMMATORY DISEASES JANSSEN PHARMACEUTICA N.V. (BE) 2004-04-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043331-A1 Substituted 3-(2,5-disubstituted)pyridyl-4-aryl pyrroles for treating inflammatory diseases TNF, TSLP, IRAK1 ALDH1A1 1528/4885GAA 2159/4885PKM 960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback